| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| CN¥0.25 | -28.57% | ||
| CN¥0.05 | -75% | ||
| CN¥0.20 | 122.22% | ||
| CN¥0.35 | 45.83% | ||
| CN¥0.09 | -65.38% | ||
| CN¥0.26 | 188.89% | ||
| CN¥0.24 | 300% | ||
| CN¥0.06 | -50% | ||
| CN¥0.12 | 300% | ||
| CN¥0.03 | 200% | ||
| CN¥0.01 | 0% | ||
| CN¥0.01 | -85.71% | ||
| CN¥0.07 | 133.33% | ||
| CN¥0.03 | |||
Hunan Fangsheng Pharmaceutical Co Ltd pays a dividend yield (FWD) of 2.17%.
- ISIN
- WKN
- Symbol / Exchange
- / XSHG
- Value
- €1.48
- Dividend frequency
- biannually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Hunan Fangsheng Pharmaceutical Co Ltd paid a dividend of CN¥0.25. For the next 12 months, Hunan Fangsheng Pharmaceutical Co Ltd is expected to pay a dividend of CN¥0.25. This corresponds to a dividend yield of approximately 2.17%.
- The dividend yield of Hunan Fangsheng Pharmaceutical Co Ltd is currently 2.17%.
- Hunan Fangsheng Pharmaceutical Co Ltd pays biannually dividends. This is paid in the months of June, October.
- The next dividend for Hunan Fangsheng Pharmaceutical Co Ltd is expected in June.
- Hunan Fangsheng Pharmaceutical Co Ltd paid dividend every year within the last 10 years.
- Dividends of CN¥0.25 are expected for the next 12 months. This corresponds to a dividend yield of 2.17%.
- Hunan Fangsheng Pharmaceutical Co Ltd is assigned to the sector "Health Care".
- The last stock split of Hunan Fangsheng Pharmaceutical Co Ltd was on 5 May 2016 in the ratio 30:10.
- To receive the last dividend of Hunan Fangsheng Pharmaceutical Co Ltd on 21 October 2024 in the amount of CN¥0.05 you had to have the stock in your portfolio before the ex-day on 21 October 2024.
- The last dividend was paid on 21 October 2024.
- In 2022, dividends of CN¥0.24 were paid by Hunan Fangsheng Pharmaceutical Co Ltd.
- Dividends from Hunan Fangsheng Pharmaceutical Co Ltd are paid in Chinese Yuan.
- The headquarters of Hunan Fangsheng Pharmaceutical Co Ltd is located in China.